Andreas Brønden

Andreas Brønden

Clinical Associate Professor


Publication year:
  1. 2023
  2. Published

    Effects of DPP-4 inhibitors, GLP-1 receptor agonists, SGLT-2 inhibitors and sulphonylureas on mortality, cardiovascular and renal outcomes in type 2 diabetes: A network meta-analyses-driven approach

    Brønden, Andreas, Christensen, Mikkel Bring, Glintborg, D., Snorgaard, O., Kofoed-Enevoldsen, A., Madsen, G. K., Toft, K., Kristensen, J. K., Højlund, K., Hansen, T. K., Søndergaard, E. & Hansen, K. B., 2023, In: Diabetic Medicine. 40, 8, 12 p., e15157.

    Research output: Contribution to journalReviewResearchpeer-review

  3. Published

    Effects of levothyroxine substitution therapy on hunger and food intake in individuals with hypothyroidism

    Medici, B. R., Nygaard, Birte, la Cour, J. L., Krakauer, M., Brønden, Andreas, Sonne, M. P., Holst, Jens Juul, Rehfeld, Jens Frederik, Vilsbøll, Tina, Faber, J. & Knop, Filip Krag, 2023, In: Endocrine Connections. 12, 10, 14 p., e230314.

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Published

    Liraglutide changes postprandial responses of gut hormones involved in the regulation of gallbladder motility

    Nerild, H. H., Brønden, Andreas, Gether, I. M., Hellmann, P. H., Baekdal, M., Gillum, M. P., Svenningsen, J. S., Hartmann, Bolette, Rathor, N., Kudiyanur Muniraju, H. A., Rehfeld, Jens Frederik, Holst, Jens Juul, Vilsbøll, Tina, Sonne, David Peick & Knop, Filip Krag, 2023, In: Diabetes, Obesity and Metabolism. 25, 6, p. 1632-1637

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Published

    Tirzepatide. Dual GLP-1/GIP receptor agonist, Treatment of type 2 diabetes and obesity

    Jensen, T. L., Brønden, Andreas, Karstoft, Kristian, Sonne, David Peick & Christensen, Mikkel Bring, 2023, In: Drugs of the Future. 48, 3, p. 179-196 18 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

ID: 334153580